Business
XPC: Q1 2026 saw higher sales, deeper commercialization, and a strengthened IP position
XPC: Q1 2026 saw higher sales, deeper commercialization, and a strengthened IP position
About this update from Xp Chemistries Ab
Net sales rose to 133 TSEK in Q1 2026, but losses widened to -3,068 TSEK. Operational focus shifted to commercialization, with technical milestones achieved in scale-up and a key patent granted in Japan. Liquidity improved, and the company is positioned for growth in sustainable feed additives.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.